Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Picankibart in Patients With Active Psoriatic Arthritis — Stella

Home/Psoriatic Arthritis/A Study of Picankibart in Patients With Active Psoriatic Arthritis

View on ClinicalTrials.gov

Recruiting

Back to Psoriatic Arthritis trials

A Study of Picankibart in Patients With Active Psoriatic Arthritis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Enrollment target

~222 participants

Started

December 2025

Primary completion

December 2029

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.